ATC code G02
ATC code G02 Other gynecologicals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup G02 is part of the anatomical group G Genito-urinary system and sex hormones.[4]
| ATC code G: Genito-urinary system and sex hormones |
|---|
|
| ATCvet only |
|
| Other ATC codes |
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QG02.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
G02A Uterotonics
G02AB Ergot alkaloids
- G02AB01 Methylergometrine
- G02AB02 Ergot alkaloids
- G02AB03 Ergometrine
- QG02AB53 Ergometrine, combinations
G02AC Ergot alkaloids and oxytocin including analogues, in combination
- G02AC01 Methylergometrine and oxytocin
- QG02AC90 Ergometrine and oxytocin
G02AD Prostaglandins
- G02AD01 Dinoprost
- G02AD02 Dinoprostone
- G02AD03 Gemeprost
- G02AD04 Carboprost
- G02AD05 Sulprostone
- G02AD06 Misoprostol
- QG02AD90 Cloprostenol
- QG02AD91 Luprostiol
- QG02AD92 Fenprostalene
- QG02AD93 Tiaprost
- QG02AD94 Alfaprostol
- QG02AD95 Etiproston
G02B Contraceptives for topical use
G02BA Intrauterine contraceptives
- G02BA01 Plastic IUD
- G02BA02 Plastic IUD with copper
- G02BA03 Plastic IUD with progestogen
G02BB Intravaginal contraceptives
- G02BB01 Vaginal ring with progestogen and estrogen
- G02BB02 Vaginal ring with progestogen
G02C Other gynecologicals
G02CA Sympathomimetics, labour repressants
- G02CA01 Ritodrine
- G02CA02 Buphenine
- G02CA03 Fenoterol
- QG02CA90 Vetrabutin
- QG02CA91 Clenbuterol
G02CB Prolactin inhibitors
- G02CB01 Bromocriptine
- G02CB02 Lisuride
- G02CB03 Cabergoline
- G02CB04 Quinagolide
- G02CB05 Metergoline
- G02CB06 Terguride
G02CC Anti-inflammatory products for vaginal administration
- G02CC01 Ibuprofen
- G02CC02 Naproxen
- G02CC03 Benzydamine
- G02CC04 Flunoxaprofen
G02CX Other gynecologicals
- G02CX01 Atosiban
- G02CX02 Flibanserin
- G02CX03 Agni casti fructus
- G02CX04 Cimicifugae rhizoma
- G02CX05 Bremelanotide
- G02CX06 Fezolinetant
- QG02CX90 Denaverine
- QG02CX91 Lotrifen
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code G02". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QG02". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.